Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Directed Evolution . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117210426A reveals enzyme mutant for chiral alcohol synthesis. Offers cost reduction in API manufacturing and reliable pharmaceutical intermediate supplier solutions.
Patent CN108823179A reveals high-efficiency transaminase mutant for R-3-aminobutanol, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112359036B discloses engineered nitrilase mutants for efficient synthesis of pregabalin chiral intermediates, offering significant cost reduction in API manufacturing.
Patent CN114807246A details high-efficiency enzymatic reduction for chiral alcohols, offering superior stereoselectivity and industrial scalability for pharmaceutical intermediates.
Patent CN113201516A details a novel P-nitrobenzyl esterase mutant for solvent-free L-menthol production, offering superior stereoselectivity and cost-effective manufacturing.